Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,539,915 papers from all fields of science
Search
Sign In
Create Free Account
0.98 ML Etanercept 50 MG/ML Auto-Injector
Known as:
etanercept 50 MG per 0.98 ML Auto-Injector
, ETANERCEPT 50MG/ML INJ SURECLICK [VA Product]
, etanercept 50 MG in 0.98 ML Auto-Injector
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Narrower (1)
0.98 ML Etanercept 50 MG/ML Auto-Injector [Enbrel]
Arthritis, Psoriatic
Auto-Injector
Drug Allergy
Etanercept
Expand
Broader (1)
Other antirheumatics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Etanercept biosimilar SB4 in the treatment of plaque‐type psoriasis and psoriatic arthritis: a single‐centre, observational, retrospective, real‐life study
A. Giunta
,
V. Manfreda
,
M. Esposito
,
E. Del Duca
,
L. Bianchi
British Journal of Dermatology
2019
Corpus ID: 143434028
The approval of the etanercept biosimilar SB4 (Brenzys, Benepali; Samsung Bioepis Co., Ltd.) for psoriasis and psoriatic…
Expand
Review
2019
Review
2019
AB1031 ETANERCEPT-INDUCED LUPUS-LIKE SYNDROME IN THE BOY WITH IDIOPATHIC DERMATOMYOSITIS OR DELAYED MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS?
M. Kaleda
,
I. Nikishina
Abstracts Accepted for Publication
2019
Corpus ID: 196523428
Background Treatment of juvenile onset rheumatic diseases (RD) is an ongoing problem because of the more aggressive disease…
Expand
2018
2018
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
P. Gisondi
,
L. Bianchi
,
+9 authors
G. Girolomoni
British Journal of Dermatology
2018
Corpus ID: 52161595
Etanercept is a recombinant tumour necrosis factor α (TNF-α) soluble receptor fused to the Fc fragment of human immunoglobulin G1…
Expand
2015
2015
Michaelis–Menten elimination kinetics of etanercept, rheumatoid arthritis biologics, after intravenous and subcutaneous administration in rats
Byung-yo Lee
,
K. Kwon
,
Min-Soo Kim
,
I. Baek
European journal of drug metabolism and…
2015
Corpus ID: 256097260
Etanercept was approved by the Food and Drug Administration (FDA) in 2010 as a biologic agent for the treatment of rheumatoid…
Expand
2013
2013
SureClick® (Darbepoetin alfa) can improve perceived satisfaction and competence for anemia treatment and increase self-administration in non-dialyzed patients with chronic kidney disease.
X. Bonafont
,
R. Romero
,
+6 authors
M. Cucala
Nefrología
2013
Corpus ID: 18598412
BACKGROUND AND AIMS SureClick® is a prefilled pen for administration of darbepoetin alfa (DA) that is ready-to-use. We explored…
Expand
2010
2010
PRESTA Defines Etanercept Dosing for Psoriasis Plus PsA
B. Jancin
2010
Corpus ID: 57040780
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE